Evidence is accumulating that elevated circulating insulin-like growth fact
or I (IGF-I) is related to increased cancer risk. The identification of hor
monal, reproductive and lifestyle characteristics influencing its synthesis
and bioavailability is of particular interest. Data from 400 women, who se
rved as controls in two case-control studies nested within the same prospec
tive cohort study, were combined. IGF-I, IGF-binding proteins 1, 2 and 3 (I
GFBP-1, -2, -3) and insulin were measured in serum samples from all subject
s and cotinine in 186 samples. Age appears to be the most important determi
nant of total IGF-I levels in women. Anthropometric measures, such as body
mass index (BMI) or waist-to-hip ratio (WHR) do not seem to influence total
IGF-I concentrations in peripheral blood, but may modulate IGF-I bioavaila
bility through insulin-dependent changes in IGFBP-1 and -2 concentrations.
Age at menarche, phase of the menstrual cycle at blood draw, parity, menopa
use, past oral contraceptive or hormone replacement therapy use, and tobacc
o smoking do not appear to exert an independent effect on IGF-I and its bin
ding proteins. There was some suggestion that regular physical activity may
increase total IGF-I and that women with positive family history of breast
cancer might have higher IGF-I levels than those without such diagnosis in
their relatives. (C) 2001 Lippincott Williams & Wilkins.